Sign In
Pricing

293790 (Harmonized System 2002 for 6-digit)

2022
World Trade $500MRnk 3042 / 4939
2022
Top Exporter | Top Importer $129M | $112MGermany | Switzerland
2022
Product Complexity 1.12Rnk 627 / 4946
2021 - 2022
Export Growth (CAGR) 17.9%Rnk 989 / 4939
2022
Share of World Trade 0.0021%Rnk 3042 / 4939

About

Overview This page contains the latest trade data of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937. In 2022, Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were the world's 3042nd most traded product, with a total trade of $500M. Between 2021 and 2022 the exports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 grew by 17.9%, from $424M to $500M. Trade in Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 represent 0.0021% of total world trade.

Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 are a part of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and....

Exports In 2022 the top exporters of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937  were Germany ($129M), China ($93.5M), Ireland ($63.1M), India ($39.7M), and France ($39.4M).

Imports In 2022 the top importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Switzerland ($112M), United States ($93.3M), France ($68.3M), India ($56.1M), and Germany ($34.7M).

Ranking Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 ranks 627th in the Product Complexity Index (PCI).

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)Germany$129M
Top Destination (2022)Switzerland$112M

In 2022 Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were the world's 3042nd most traded product (out of 4,939).

In 2022, the top exporters of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Germany ($129M), China ($93.5M), Ireland ($63.1M), India ($39.7M), and France ($39.4M).

In 2022, the top importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Switzerland ($112M), United States ($93.3M), France ($68.3M), India ($56.1M), and Germany ($34.7M).

Explore Visualizations

Exporters of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 (2022)
[Click to Select a Country]

Importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2021 -  2022)Germany$91.6M
Top Destination Growth (2021 -  2022)Switzerland$104M

Between 2021 and 2022, the exports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 grew the fastest in Germany ($91.6M), France ($32.2M), India ($6.44M), Denmark ($6.4M), and Chinese Taipei ($2.9M).

Between 2021 and 2022, the fastest growing importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Switzerland ($104M), Russia ($5.56M), Austria ($5.08M), United States ($4.86M), and Canada ($3.38M).

Explore Visualizations

Exporters of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 (2021 - 2022)

Importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 (2021 - 2022)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937.

In 2022, market concentration measured using Shannon Entropy, was 3.38. This means that most of the exports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 are explained by 10 countries.

Explore Visualizations

Value of Exports in Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937

Net Trade

TOP NET EXPORTER (2022)Germany$94.7M
TOP NET IMPORTER (2022)Switzerland$109M

This map shows which countries export or import more of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937. Each country is colored based on the difference in exports and imports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Germany ($94.7M), China ($91.6M), Ireland ($53.6M), Italy ($26.5M), and Iceland ($12.9M).

In 2022, the countries that had a largest trade value in imports than in exports of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 were Switzerland ($109M), United States ($60.1M), France ($28.9M), Russia ($18.4M), and India ($16.4M).

Net Trade (2022)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937.
It is possible to select the main countries that export or import Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937 by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms